Caprolactam Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.60 Cr
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.97 Cr
- Revenue Growth 298.35%
- Profit Growth 298.77%
- Ebitda 922.62%
- Net Worth 90.91%
- Total Assets 11.48%
About Caprolactam Chemicals
Caprolactam Chemicals Limited (CCL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 November 1988 and has a history of 36 years and three months. Its registered office is in Raigarh, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 507486.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.60 Cr.
The company currently has active open charges totaling ₹2.97 Cr.
The Key Managerial Personnel (KMP) at Caprolactam Chemicals Limited India are Siddharth Bhanushali as CFO and Dolly Mehta as Company Secretary. Kamlesh Joisher, Zaver Bhanushali, Siddharth Bhanushali, and Two other members serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24110MH1988PLC049683
- Company No.
049683
- Stock Symbol
BSE : 507486
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Nov 1988
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Caprolactam Chemicals?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Zaver Bhanushali ![]() | Managing Director | 01-Aug-2010 | Current |
Siddharth Bhanushali ![]() | CFO | 30-Apr-2015 | Current |
Dolly Mehta ![]() | Company Secretary | 05-Oct-2019 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kamlesh Joisher ![]() | Director | 22-May-2024 | Current |
Siddharth Bhanushali ![]() | Whole-Time Director and Cfo | 29-Jan-2007 | Current |
Poonam Bhanushali ![]() | Director | 21-Apr-2018 | Current |
Viren Jasani ![]() | Director | 22-May-2024 | Current |
Financial Performance of Caprolactam Chemicals.
Caprolactam Chemicals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 298.35% increase. The company also saw a substantial improvement in profitability, with a 298.77% increase in profit. The company's net worth Soared by an impressive increase of 90.91%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Caprolactam Chemicals?
In 2023, Caprolactam Chemicals had a promoter holding of 52.60% and a public holding of 47.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹2.97 Cr
₹0
Charges Breakdown by Lending Institutions
- The United Westrn Bank Ltd : 2.86 Cr
- Bank Of Baroda : 0.08 Cr
- Mashreq Bank : 0.03 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
06 Oct 1997 | The United Westrn Bank Ltd | ₹1.43 Cr | Open |
12 Sep 1997 | Mashreq Bank | ₹0.33 M | Open |
20 Sep 1994 | The United Westrn Bank Ltd | ₹1.43 Cr | Open |
31 Oct 1992 | Bank Of Baroda | ₹0.80 M | Open |
How Many Employees Work at Caprolactam Chemicals?
Caprolactam Chemicals has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Caprolactam Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caprolactam Chemicals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.